ReEmerge, Inc.
PrivateLast Round
Series A
Sep 15, 2026
Total Funding Raised
$37M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
ReEmerge, Inc. is a MedTech company that develops Cognitive Network Restoration Therapy (CNRT) to treat chronic cognitive impairment caused by brain injuries.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ReEmerge, Inc. Comparables
Compare ReEmerge, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nia Therapeutics | 81% | |
| Functional Neuromodulation | 75% | |
| Enspire DBS Therapy, Inc. | 68% |
ReEmerge, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 15, 2026 |
ReEmerge, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Vertical Group | Series A |
| Dendrion Ventures | Series A |
| IAG Capital Partners | Series A |
| Oxford Science Enterprises | Series A |
| 415 Capital | Series A |
| U.S. Venture Partners | Series A |
| Santé Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 15, 2026
$37M round led by U.S. Venture Partners and Santé Ventures.
Recent news
Latest coverage and updates
- receives_financingSep 15, 2026
ReEmerge, Inc. received financing of $37M in Series A on Sep 15th '26.
ReEmerge, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ReEmerge, Inc.'s valuation, stock price, and market status.
Is ReEmerge, Inc. a public or private company?
ReEmerge, Inc. is a private company.
What is the current stock price of ReEmerge, Inc.?
ReEmerge, Inc. is a private company with no public stock price. Caplight tracks ReEmerge, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is ReEmerge, Inc. worth (valuation)?
Valuation information for ReEmerge, Inc. is not publicly available.
Can I buy ReEmerge, Inc. stock?
ReEmerge, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ReEmerge, Inc.'s last funding round?
ReEmerge, Inc.'s most recent funding round was Series A on September 15, 2026.
Who are the main investors in ReEmerge, Inc.?
Key investors in ReEmerge, Inc. include U.S. Venture Partners, Santé Ventures.
Will ReEmerge, Inc. IPO soon?
No public IPO plans have been announced for ReEmerge, Inc..
How can I track ReEmerge, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ReEmerge, Inc.'s secondary market activity and sign up for updates.